metastatic/advanced UC (mUC) - 1st Line (L1) | |
mUC - L1 - all population | |
atezolizumab based treatment | |
atezolizumab alone | IMvigor-130 ... |
atezolizumab plus SoC | IMvigor-130 ... |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -